Bleeding time in uremia: a useful test to assess clinical bleeding

Area of Science:

• Nephrology
• Hematology
• Clinical Pathology

Background:

• Uremic bleeding diathesis is a common complication of chronic kidney disease.
• Platelet dysfunction contributes to bleeding in uremia, but its severity and assessment remain challenging.

Purpose of the Study:

• To evaluate the utility of template bleeding time and platelet aggregation tests in assessing bleeding diathesis in uremic patients.
• To compare aggregometric patterns in uremic thrombocytopathy with drug-induced defects.

Main Methods:

• Modified Ivy bleeding time and platelet aggregation studies were performed on 26 uremic patients.
• Platelet aggregation was assessed using adenosine diphosphate (ADP), epinephrine, and collagen as agonists.
• Patients were categorized into bleeding and non-bleeding groups for comparison.

Main Results:

• Platelet aggregation abnormalities were generally mild, even in advanced uremia, and less severe than those caused by anti-platelet drugs.
• Inhibition of collagen-induced aggregation correlated with increased bleeding time and blood urea nitrogen levels.
• Bleeding time was more discriminative for clinical bleeding than platelet aggregation tests.

Conclusions:

• Platelet aggregometry has limited clinical utility in assessing the severity of uremic bleeding diathesis.
• Bleeding time is a more helpful parameter for evaluating bleeding risk in uremic patients.
• Distinguishing uremic from drug-induced thrombocytopathy may be possible in some cases based on aggregometric patterns.